Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1966 1
1967 2
1969 4
1970 2
1971 1
1972 4
1973 3
1974 2
1975 13
1976 7
1977 13
1978 12
1979 15
1980 18
1981 26
1982 42
1983 27
1984 40
1985 34
1986 48
1987 51
1988 40
1989 55
1990 57
1991 71
1992 71
1993 84
1994 79
1995 63
1996 93
1997 88
1998 66
1999 104
2000 109
2001 96
2002 128
2003 115
2004 141
2005 127
2006 151
2007 150
2008 185
2009 183
2010 162
2011 199
2012 208
2013 206
2014 227
2015 303
2016 314
2017 317
2018 332
2019 270
2020 351
2021 402
2022 336
2023 353
2024 206

Text availability

Article attribute

Article type

Publication date

Search Results

6,143 results

Results by year

Filters applied: . Clear all
Page 1
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, … See abstract for full author list ➔ Bateman RM, et al. Among authors: yamamoto n. Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6. Crit Care. 2016. PMID: 27885969 Free PMC article.
Ergin Ozcan, E. Senturk, C. Ugur Yilmaz, N. Orhan, N. Arican, M. Kaya, M. Kucukerden, M. Giris, U. Akcan, S. Bilgic Gazioglu, E. ...Lopez, M. Aguilar Arzapalo, L. Barradas, A. Escalante, J. Gongora, M. ...
Ergin Ozcan, E. Senturk, C. Ugur Yilmaz, N. Orhan, N. Arican, M. Kaya, M. Kucukerden, M. Giris, U. Akcan, S. Bilgic Gaz …
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.
Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, Fujihara M, Akimaru H, Sakai N, Shibata Y, Terada M, Nomiya Y, Tanishima S, Nakamura M, Kamao H, Sugita S, Onishi A, Ito T, Fujita K, Kawamata S, Go MJ, Shinohara C, Hata KI, Sawada M, Yamamoto M, Ohta S, Ohara Y, Yoshida K, Kuwahara J, Kitano Y, Amano N, Umekage M, Kitaoka F, Tanaka A, Okada C, Takasu N, Ogawa S, Yamanaka S, Takahashi M. Mandai M, et al. Among authors: yamamoto m. N Engl J Med. 2017 Mar 16;376(11):1038-1046. doi: 10.1056/NEJMoa1608368. N Engl J Med. 2017. PMID: 28296613 Free article.
M cell-targeted mucosal vaccine strategies.
Yamamoto M, Pascual DW, Kiyono H. Yamamoto M, et al. Curr Top Microbiol Immunol. 2012;354:39-52. doi: 10.1007/82_2011_134. Curr Top Microbiol Immunol. 2012. PMID: 21688209 Free PMC article. Review.
To sample antigens on mucosal surfaces in the intestine and upper respiratory tract, the immune system relies on a close collaboration between specialized antigen-sampling epithelial M cells and lymphoid cells. Depending on various factors, local antigen presentation in th …
To sample antigens on mucosal surfaces in the intestine and upper respiratory tract, the immune system relies on a close collaboration betwe …
Ultrahigh Energy Storage in 2D High-κ Perovskites.
Kim HJ, Morita S, Byun KN, Shi Y, Taniguchi T, Yamamoto E, Kobayashi M, Ebina Y, Sasaki T, Osada M. Kim HJ, et al. Among authors: yamamoto e. Nano Lett. 2023 May 10;23(9):3788-3795. doi: 10.1021/acs.nanolett.3c00079. Epub 2023 May 1. Nano Lett. 2023. PMID: 37126862
Here, we present a rational approach for designing ultrahigh energy storage capacitors using two-dimensional (2D) high-kappa dielectric perovskites (Ca(2)Na(m-3)Nb(m)O(3m+1); m = 3-6). Individual Ca(2)Na(m-3)Nb(m)O(3m+1) nanosheets exhibit an ul …
Here, we present a rational approach for designing ultrahigh energy storage capacitors using two-dimensional (2D) high-kappa dielectric pero …
Impact of body mass index on the severity of bexarotene-associated hypertriglyceridemia: A post hoc analysis of an open-labeled clinical study of combined bexarotene and phototherapy in Japanese patients with cutaneous T-cell lymphoma.
Sanagawa A, Hayakawa T, Nishida E, Yamamoto A, Ikumi K, Mori Y, Hotta Y, Kimura K, Furukawa-Hibi Y, Morita A. Sanagawa A, et al. Among authors: yamamoto a. J Dermatol. 2023 Jul;50(7):917-926. doi: 10.1111/1346-8138.16801. Epub 2023 Apr 11. J Dermatol. 2023. PMID: 37041679
Twenty-five subjects were divided into two subgroups: normal and underweight (body mass index [BMI] <25 kg/m(2) group) and overweight and obese (BMI 25 kg/m(2) group) patients. The overall incidence of hypertriglyceridemia was 81.3% (13/16) in the BMI <25 kg/ …
Twenty-five subjects were divided into two subgroups: normal and underweight (body mass index [BMI] <25 kg/m(2) group) and overwei …
Microphthalmia-associated transcription factor in the Wnt signaling pathway.
Saito H, Yasumoto K, Takeda K, Takahashi K, Yamamoto H, Shibahara S. Saito H, et al. Among authors: yamamoto h. Pigment Cell Res. 2003 Jun;16(3):261-5. doi: 10.1034/j.1600-0749.2003.00039.x. Pigment Cell Res. 2003. PMID: 12753399 Review.
Expression of MITF-M is under the regulation of the melanocyte-specific promoter (M promoter) of the MITF gene, and transcription from the M promoter is induced by Wnt signals through a nuclear mediator, lymphoid-enhancing factor 1 (LEF-1). ...MITF-M t …
Expression of MITF-M is under the regulation of the melanocyte-specific promoter (M promoter) of the MITF gene, and transcript …
Oocyte extracts for the study of meiotic M-M transition.
Ohsumi K, Yamamoto TM, Iwabuchi M. Ohsumi K, et al. Among authors: yamamoto tm. Methods Mol Biol. 2006;322:445-58. doi: 10.1007/978-1-59745-000-3_32. Methods Mol Biol. 2006. PMID: 16739743 Review.
In oocyte extracts, the activity of cyclin B-Cdc2 complexes, the M phase inducer, fluctuates in the same manner as it does in maturing oocytes during the MI to MII transition period. By the use of oocyte extracts, it has been found that incomplete inactivation of Cdc2 at t …
In oocyte extracts, the activity of cyclin B-Cdc2 complexes, the M phase inducer, fluctuates in the same manner as it does in maturin …
Association Between Glycemic Traits and Primary Open-Angle Glaucoma: A Mendelian Randomization Study in the Japanese Population.
Hanyuda A, Goto A, Nakatochi M, Sutoh Y, Narita A, Nakano S, Katagiri R, Wakai K, Takashima N, Koyama T, Arisawa K, Imoto I, Momozawa Y, Tanno K, Shimizu A, Hozawa A, Kinoshita K, Yamaji T, Sawada N, Iwagami M, Yuki K, Tsubota K, Negishi K, Matsuo K, Yamamoto M, Sasaki M, Tsugane S, Iwasaki M. Hanyuda A, et al. Among authors: yamamoto m. Am J Ophthalmol. 2023 Jan;245:193-201. doi: 10.1016/j.ajo.2022.09.004. Epub 2022 Sep 23. Am J Ophthalmol. 2023. PMID: 36162535
m_{b} at m_{H}: The Running Bottom Quark Mass and the Higgs Boson.
Aparisi J, Fuster J, Irles A, Rodrigo G, Vos M, Yamamoto H, Hoang A, Lepenik C, Spira M, Tairafune S, Yonamine R. Aparisi J, et al. Among authors: yamamoto h. Phys Rev Lett. 2022 Mar 25;128(12):122001. doi: 10.1103/PhysRevLett.128.122001. Phys Rev Lett. 2022. PMID: 35394294
We present a new measurement of the bottom quark mass in the MS[over ] scheme at the renormalization scale of the Higgs boson mass from measurements of Higgs boson decay rates at the LHC: m_{b}(m_{H})=2.60_{-0.31}^{+0.36} GeV. The measurement has a negligible theory …
We present a new measurement of the bottom quark mass in the MS[over ] scheme at the renormalization scale of the Higgs boson mass from meas …
Treatment of oral cancer using magnetized paclitaxel.
Nakakaji R, Umemura M, Mitsudo K, Kim JH, Hoshino Y, Sato I, Masuda T, Yamamoto M, Kioi M, Koizumi T, Fujita T, Yokoyama U, Iida M, Sato M, Sato H, Murofushi S, Shibata S, Aoki I, Eguchi H, Tohnai I, Ishikawa Y. Nakakaji R, et al. Among authors: yamamoto m. Oncotarget. 2018 Feb 26;9(21):15591-15605. doi: 10.18632/oncotarget.24570. eCollection 2018 Mar 20. Oncotarget. 2018. PMID: 29643995 Free PMC article.
M-PTX increased apoptosis and G2/M arrest of cultured human oral cancer cell lines in the same manner as PTX. Furthermore, marked contrast intensity was obtained in magnetic resonance imaging (MRI) of M-PTX. In a mouse oral cancer model, a permanent magnet pl
M-PTX increased apoptosis and G2/M arrest of cultured human oral cancer cell lines in the same manner as PTX. Furthermore, mar
6,143 results